The Maharashtra authorities has determined to make use of hospitals connected to medical schools as therapy centres for Mucormycosis, a critical however uncommon fungal an infection now affecting coronavirus sufferers, stated Well being Minister Rajesh Tope on Tuesday.
Signs of Mucormycosis, often known as black fungus, embrace headache, fever, ache beneath the eyes, nasal or sinus congestion and partial lack of imaginative and prescient.
He stated, “There may very well be over 2,000 Mucormycosis sufferers within the state as of now and with an increasing number of COVID-19 circumstances developing, their quantity would improve for positive.”
The state authorities has determined to pick out hospitals connected to medical schools for therapy of Mucormycosis sufferers because it calls for a multidisciplinary strategy, Mr Tope stated.
He stated black fungus has a 50 per cent mortality fee and is present in COVID-19 sufferers with suppressed immunity or co-morbidities.
“A Mucormycosis affected person must be seen by numerous specialists corresponding to ENT, ophthalmologists and neurologists amongst others. We try to cowl a lot of the therapy beneath the Mahatma Phule Jan Aarogya Yojana (the state’s flagship well being scheme), the minister stated.
Commenting over the pricey therapy, he stated, I will likely be writing to the Nationwide Pharmaceutical Pricing Authority to convey down the MRP of medicines wanted for Mucormycosis therapy.”
Amphotercin-B is a key drugs required for therapy of such sufferers. Haffkine (a state-run pharma agency based mostly in Mumbai) goes float a young for one lakh injections of the drug, Mr Tope stated.
(Aside from the headline, this story has not been edited by NDTV employees and is printed from a syndicated feed.)